<DOC>
	<DOCNO>NCT01509742</DOCNO>
	<brief_summary>This trial conduct Europe . The aim trial examine effect NNC 90-1170 hypoglycaemic counterregulation subject type 2 diabetes .</brief_summary>
	<brief_title>Effect Liraglutide Glucagon Secretion Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Hypoglycemic Agents</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria />
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>